Starting July 1, 2026, Medicare is launching something new [1]. The GLP-1 Bridge program will give eligible Medicare Part D beneficiaries access to certain weight-loss medications for a $50 monthly copay.
This matters because Medicare Part D has never covered medications prescribed specifically for weight loss. That changes this summer.
What the Program Covers
The program includes three medications: Foundayo, Wegovy (injection or tablet), and Zepbound (KwikPen). Each 30-day supply costs $50.
The $50 copay does not count toward your deductible or out-of-pocket limit. It is a flat monthly cost for the duration of the program, which runs through December 31, 2027.
Who Qualifies
You need to be enrolled in a Medicare Part D plan and meet specific health criteria.
Eligibility requirements include:
- A body mass index (BMI) of 35 or higher
OR
- A BMI between 30 and 34.99 with conditions like diastolic heart failure or uncontrolled high blood pressure
An estimated 3.8 million Medicare beneficiaries could be eligible based on 2023 enrollment data [2].
Your doctor will need to submit a prior authorization request to a central processing center. Part of that process includes confirming you have received counseling on lifestyle changes while taking these medications.
Why This Matters Now
Nearly 40% of adults age 60 and older qualified as obese in 2023, according to the Centers for Disease Control and Prevention [3].
Weight reduction can improve mobility, decrease joint pain, lower blood pressure, improve blood sugar control, and reduce cardiovascular risk. For many people, those changes translate directly into maintaining independence and function.
Large clinical trials with semaglutide and liraglutide have shown reduced risk of heart attack, stroke, and cardiovascular death in high-risk adults, many of whom were over 65.
Beyond weight loss, GLP-1 medications have demonstrated the ability to reduce major cardiovascular events, combat fatty liver disease, and alleviate obesity-related complications such as knee pain, sleep apnea, and acid reflux.
What You Should Do Next
If you think you qualify, talk to your doctor. Ask whether one of these medications makes sense for your health situation.
Check with your Medicare Part D plan to confirm your coverage details. You can also visit Medicare.gov/glp1bridge [4] or call 1-800-MEDICARE (1-800-633-4227) [5] with questions.
If you are a senior care professional working with residents or clients who have obesity-related health conditions, this program is worth discussing with their care teams.
What This Could Mean for Long-Term Care Needs
From my perspective, based on years working in senior care, the chronic conditions GLP-1 medications address are often the same conditions that trigger the need for additional care support.
Uncontrolled diabetes, heart failure, limited mobility from joint pain, repeated falls – these are the situations that often lead families to start looking at home care services or assisted living options. When someone cannot safely manage stairs anymore, when medication management becomes overwhelming, when a spouse can no longer provide the physical support needed – that is when the conversation about care changes.
If GLP-1 medications help delay those triggers, even by a few years, that is time spent at home with less support. That is independence maintained longer. For many families, that shift is meaningful.
And when the time does come to explore care options – whether that is finding a home care agency, comparing assisted living communities, or understanding what memory care looks like – families deserve a clear, honest resource to help them ask the right questions and connect directly with providers.
That is what CareAvailability.com was built for. Over 115,000 providers listed nationwide. Free to search. No referral fees. No middlemen. Families contact providers directly. No data sold. Just clear information when you need it.
Resources and Citations
- Medicare GLP-1 Bridge Program Official Information
https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge - Eligibility Data (AARP)
https://www.aarp.org/medicare/glp1-weight-loss-copay-program/ - CDC and Clinical Data on GLP-1 Safety for Older Adults
https://www.aamc.org/news/are-glp-1-weight-loss-drugs-safe-older-adults - Medicare Coverage for Weight Loss Drugs
Medicare.gov/glp1bridge - Medicare Help Line
1-800-MEDICARE (1-800-633-4227)
